The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis

Dowlatshahi, Emmilia A., Wakkee, Marlies, Arends, Lidia R., Nijsten, Tamar·2014·Journal of Investigative Dermatology

DOI 10.1038/jid.2013.508

Cited by (436)

Items 101–200 of 436

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009
Kim Alexander Papp, Wayne P. F. Gulliver, Charles W Lynde, Yves P. Poulin, David Adam, Benjamin Barankin, Kirk A. Barber, Marc Bourcier, Melinda Gooderham, Lyn Guenther et al. · 2016 · Journal of Cutaneous Medicine and Surgery
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders
Maurizio Pompili, Marco Innamorati, Alberto Maria Forte, Denise Erbuto, Dorian A. Lamis, Alessandra Narcisi, Claudia Rea, Diego Orsini, Andrea D’Arino, Annalisa Arcese et al. · 2017 · International Journal of Psychiatry in Clinical Practice
Secukinumab in the treatment of psoriasis: patient selection and perspectives
Eric Yang, Kristen M. Beck, Wilson J. Liao · 2018 · Psoriasis Targets and Therapy
Assessing the psychological burden of patients with hidradenitis suppurativa
Verena Gerlinde Frings, Boris Bauer, Manuel Glöditzsch, Matthias Goebeler, Dagmar Presser · 2019 · European Journal of Dermatology
Risk of Depression in Patients With Psoriatic Disease: A Systematic Review and Meta-Analysis
Aysha Lukmanji, Robert Barkev Basmadjian, Isabelle A. Vallerand, Scott Burton Patten, Karen L. Tang · 2020 · Journal of Cutaneous Medicine and Surgery
Psoriasis and Psoriatic Arthritis Have a Major Impact on Quality of Life and Depressive Symptoms: A Cross-Sectional Study of 300 Patients
Natalie Frede, Sonja Hiestand, Franziska Schauer, Dominique Endres, Ludger Tebartz van Elst, Markus Zeisbrich, Nils Craig-Mueller, Stephanie Finzel, Jens Thiel, Reinhard Edmund Voll et al. · 2023 · Rheumatology and Therapy
Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden
Zeno Fiocco, Sophie Kupf, Leilah Patzak, Till A. Kämmerer, Teodora Pumnea, Lars Einar French, Markus Reinholz · 2021 · Acta Dermato Venereologica
Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study
Spyridon Gkalpakiotis, Monika Arenbergerová, Petra Gkalpakioti, Jana Potočková, Petr Arenberger, Pavel J. Kraml · 2016 · The Journal of Dermatology
The economic burden of psoriasis with high comorbidity among privately insured patients in the United States
Dominic Pilon, Amanda Teeple, Maryia Zhdanava, Martin Ladouceur, Hoi Ching Cheung, Erik Muser, Patrick Lefèbvre · 2018 · Journal of Medical Economics
Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient‐reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials
Diamant Thaçi, Alexa B. Kimball, Peter Anthony Foley, Yves P. Poulin, Eugenia Levi, R. Chen, Steven R. Feldman · 2016 · Journal of the European Academy of Dermatology and Venereology
Major depressive disorders accompanying autoimmune diseases – Response to treatment
Katarzyna I. Białek, Piotr Lech Czarny, Justyna Strycharz, Tomasz Śliwiński · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Interleukine-17 Administration Modulates Adult Hippocampal Neurogenesis and Improves Spatial Learning in Mice
Matanel Tfilin, Gadi Turgeman · 2019 · Journal of Molecular Neuroscience
Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery
Siddharth Singh, Rajendra Awasthi · 2023 · Journal of Drug Delivery Science and Technology
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials
Kenneth B. Gordon, Richard G B Langley, Richard Bruce Warren, Yukari Okubo, David M. Rosmarin, Mark Lebwohl, Luke Peterson, Cynthia Madden, Dirk De Cuyper, Owen R Davies et al. · 2023 · British Journal of Dermatology
Stigma, Social Appearance Anxiety and Coping in Men and Women Living with Skin Conditions: A Mixed Methods Analysis
Olivia Hughes, Paul B. Hutchings, Ceri Phelps · 2021 · Skin Health and Disease
Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure
Christopher E.M. Griffiths, Melinda Gooderham, Jean‐Frédéric Colombel, Tadashi Terui, Ana P. Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt · 2022 · Dermatology and Therapy
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial
Masatoshi Abe, Chikako Nishigori, Hideshi Torii, Hironobu Ihn, Kei Ito, Makoto Nagaoka, Naoki Isogawa, Isao Kawaguchi, Yukiko Tomochika, Mihoko Kobayashi et al. · 2017 · The Journal of Dermatology
Epidemiology of Depression in Patients with Psoriasis: A Nationwide Population-based Cross-sectional Study
Stephen Chu‐Sung Hu, Guanhua Chen, Hung‐Pin Tu · 2019 · Acta Dermato Venereologica
Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis
Qian Cai, Amanda Teeple, Bingcao Wu, Erik Muser · 2019 · Journal of Medical Economics
Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study
Donja Homayoon, Michaela Hiebler‐Ragger, M. Zenker, Wolfgang Weger, Human‐Friedrich Unterrainer, Elisabeth Aberer · 2020 · Acta Dermato Venereologica
Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients
Teodora Larisa Timiș, Lehel Beni, Teodora Mocan, Ioan Alexandru Florian, Remus-Ioan Orăsan · 2023 · Life
Common mental health disorders in adults with inflammatory skin conditions: nationwide population-based matched cohort studies in the UK
Alasdair David Henderson, Elizabeth Adesanya, Amy R. Mulick, Julian Matthewman, Nhung Vu, Firoza Davies, Catherine H. Smith, Joseph Hayes, Kathryn Elizabeth Mansfield, Sinéad Langan · 2023 · BMC Medicine
Major depressive disorder increased risk of psoriasis: A propensity score matched cohort study
Yi‐Hsien Chen, Wei‐Ming Wang, I‐Hsun Li, Hui‐Han Kao, Chin‐Bin Yeh, Li‐Ting Kao · 2020 · Journal of Affective Disorders
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
Marco Galluzzo, S. D’Adamio, Elena Campione, Sara Mazzilli, Luca Bianchi, Marina Talamonti · 2018 · Journal of Dermatological Treatment
Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
Lotte A. Minnema, Thijs J. Giezen, Patrick Cyriel Souverein, Toine C. G. Egberts, Hubert G. M. Leufkens, Helga Gardarsdóttir · 2019 · Drug Safety
Depressive-like behaviors in mice with Imiquimod-induced psoriasis
Jianning Guo, Yu Liu, Xiaoyao Guo, Yujiao Meng, Cong Qi, Jingxia Zhao, Tingting Di, Lu Zhang, Xinwei Guo, Yazhuo Wang et al. · 2020 · International Immunopharmacology
Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis: a Danish nationwide cohort study
Alexander Egeberg, Usman Khalid, Gunnar Gislason, Lotus Mallbris, Lone Skov, Peter Riis Hansen · 2015 · British Journal of Dermatology
Sex and Age Influence the Associated Risk of Depression in Patients with Psoriasis: A Retrospective Population Study Based on Diagnosis and Drug-Use
Albert Duvetorp, Ulrich Mrowietz, Mats Nilsson, Oliver Seifert · 2020 · Dermatology
Prevalence and Odds of Signs of Depression and Anxiety in Patients with Lichen Planus: Systematic Review and Meta-analyses
Isabelle Jalenques, Sophie Lauron, S Almon, B Pereira, Michel D'Incan, Fabien Rondepierre · 2020 · Acta Dermato Venereologica
Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis
Ru Dai, Bingjiang Lin, Xuetong Zhang, Yuchen Lou, Suling Xu · 2021 · Dermatology and Therapy
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang · 2023 · Current Neuropharmacology
Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and 18fluorodeoxyglucose (FDG) positron emission tomography (PET)
Seong‐Jang Kim, Min‐Young Park, Kyoungjune Pak, Junhee Han, Gun‐Wook Kim, Hoon‐Soo Kim, Hyun-Chang Ko, Moon‐Bum Kim, Byung‐Soo Kim · 2018 · Journal of Dermatological Treatment
Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study
Ourania Founta, Karoline Adamzik, Anne‐Marie Tobin, Brian Kirby, David Hevey · 2018 · Journal of Clinical Psychology in Medical Settings
Identification of potential key mRNAs and LncRNAs for psoriasis by bioinformatic analysis using weighted gene co-expression network analysis
Huotao Li, Chao Yang, Jiao Zhang, Wei Zhong, Lei Zhu, Yongfeng Chen · 2020 · Molecular Genetics and Genomics
Describing the burden of the COVID‐19 pandemic in people with psoriasis: findings from a global cross‐sectional study
Satveer K. Mahil, Mark Yates, Zenas Z N Yiu, Sinéad Langan, Teresa Tsakok, Nick Dand, Kayleigh J. Mason, Helen McAteer, Freya Meynell, Bola Coker et al. · 2021 · Journal of the European Academy of Dermatology and Venereology
Psoriasis
Eleanor Higgins · 2017 · Medicine
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
Marthe‐Lisa Schaarschmidt, Christian Kromer, Raphael M. Herr, Astrid Schmieder, Diana Sonntag, Sergij Goerdt, Wiebke K. Peitsch · 2015 · PLoS ONE
Association of Psoriasis with Psychiatric Hospitalization in United States Children and Adults
Kevin R. Patel, Harrison H. Lee, Supriya Rastogi, Vivek Singam, Paras P. Vakharia, Jonathan I. Silverberg · 2019 · Dermatology
Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis
Michelle Skornicki, Patricia Prince, Robert Suruki, Edward S. Lee, Anthony M. Louder · 2021 · Advances in Therapy
The prevalence of alexithymia in psoriasis: A systematic review and meta-analysis
Fu-You Tang, Qin Xiong, Ting Gan, Lei Yuan, Qian Liao, Yu-Feng Yu · 2022 · Journal of Psychosomatic Research
Psoriasis for the primary care practitioner
Melodie S. Young, Lakshi M. Aldredge, Patti A. Parker · 2017 · Journal of the American Association of Nurse Practitioners
Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
Gayle E. van der Kraaij, Deepak Balak, Celine I. Busard, O.D. van Cranenburgh, Y. Chung, R.J.B. Driessen, M. de Groot, Elke M. G. J. de Jong, P. M. J. H. Kemperman, Wim J A de Kort et al. · 2019 · British Journal of Dermatology
Increased risk of major depressive disorder among probands with psoriasis and unaffected siblings: a nationwide population‐based study
Y.‐X. Dai, Celia Chen, Yu-Chan Tai, Y.‐T. Chang, T.‐J. Chen, Mu‐Hong Chen · 2020 · Journal of the European Academy of Dermatology and Venereology
Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns – a cross-sectional study
Neuza Silva, Matthias Augustin, Caroline Hilbring, Catharina C. von Stülpnagel, Rachel Sommer · 2022 · BMJ Open
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
Murlidhar Rajagopalan, Sunil Dogra, Abir Saraswat, Sachin Varma, Pravin Banodkar · 2021 · Psoriasis Targets and Therapy
Biologicals and small molecules in psoriasis: A systematic review of economic evaluations
Christian Kromer, Daniel Celis, Diana Sonntag, Wiebke K. Peitsch · 2018 · PLoS ONE
Complementary and integrative therapies for psoriasis: Looking forward
Katerina Damevska, Katlein França, Torello Lotti, Suzana Nikolovska, Nora Pollozhani · 2018 · Dermatologic Therapy
Pathophysiological basis of systemic treatments in psoriasis
Sebastian Volc, Kamran Ghoreschi · 2016 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk
Maria J. E. Visser, Gareth S. Tarr, Etheresia Pretorius · 2021 · Frontiers in Immunology
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study
Michele Fabrazzo, Francesca Romano, Marzia Arrigo, Rosa Valentina Puca, Antonietta Fuschillo, Valeria De Santis, Gaia Sampogna, Giulia Maria Giordano, Francesco Catapano, Ada Lo Schiavo · 2022 · International Journal of Environmental Research and Public Health
Brain inflammation and psoriasis: a [11C]-(R)-PK11195 positron emission tomography study
Hamish J. A. Hunter, Rainer Hinz, Alexander Gerhard, Peter S. Talbot, Zhangjie Su, G. Holland, Stephen J. Hopkins, Christopher E.M. Griffiths, Christine Elise Kleyn · 2015 · British Journal of Dermatology
Gut microbiota dysbiosis at the interface of neuropsychiatric disorders and their dermatological comorbidities
Brittany Hawkins, Maddison Montgomery, Gabriela Bokota, Maria Santoyo, Erica Giron, Ahmed Eltokhi · 2025 · Gut Microbes
Apremilast for psoriasis treatment
J.M. Carrascosa, E. del Alcázar · 2020 · Giornale Italiano di Dermatologia e Venereologia
The role of diet in the management of psoriasis: a scoping review
Poppy Hawkins, Kate Earl, Thanasis G. Tektonidis, Rosalind Fallaize · 2023 · Nutrition Research Reviews
Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
Karina A. Wierzbowska-Drabik, Aleksandra Lesiak, Małgorzata Skibińska, Michał Niedźwiedź, Jarosław Damian Kasprzak, Joanna Narbutt · 2021 · International Journal of Molecular Sciences
Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry
Abby Susan Van Voorhees, Marc A. Mason, Leslie R. Harrold, Ning Guo, Adriana Guana, Haijun Tian, Vivian Herrera, Bruce E Strober · 2019 · Journal of Dermatological Treatment
Psoriasis Comorbidities and Their Treatment Impact
Mark Taliercio, Mark Lebwohl · 2024 · Dermatologic Clinics
Smoking is an independent but not a causal risk factor for moderate to severe psoriasis: A Mendelian randomization study of 105,912 individuals
Charlotte Näslund‐Koch, Signe Vedel‐Krogh, Stig E. Bojesen, Lone Skov · 2023 · Frontiers in Immunology
The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database
Catherine Vasilakis‐Scaramozza, Rebecca Persson, Katrina Wilcox Hagberg, Susan Sara Jick · 2020 · Journal of the European Academy of Dermatology and Venereology
The prevalence of psychiatric comorbidity in patients with prurigo nodularis
ShubhM Singh, Lovee Dhawan, Ajit Avasthi, MSendhil Kumaran, Tarun K. Narang · 2018 · Indian Dermatology Online Journal
Association of Psoriasis With Mental Health Disorders in South Korea
Chul Hwan Bang, Jae Woong Yoon, Jae Heon Chun, Ju Hee Han, Young Min Park, Suk Jun Lee, Ji Hyun Lee · 2019 · JAMA Dermatology
Skin Diseases in Patients with Primary Psychiatric Disorders
Paraskevi Mavrogiorgou, Corinna Mersmann, Gabriele Gerlach, Stephan Herpertz, Georg Juckel · 2020 · Psychiatry Investigation
Periodontitis and the impact of oral health on the quality of life of psoriatic individuals: a case-control study
Amanda Almeida Costa, Luís Otávio Miranda Cota, Victor Silva Mendes, Alcione Maria Soares Dutra Oliveira, Renata Magalhães Cyrino, Fernando Oliveira Costa · 2020 · Clinical Oral Investigations
Depressive, anxiety, stress, and insomnia symptoms in patients with psoriasis: a cross-sectional study
Moetaza M. Soliman · 2020 · Advances in Dermatology and Allergology
Negative perceptions and emotional impact of striae gravidarum among pregnant women
Kaveri Karhade, Megan L. Lawlor, Heather A. Chubb, Timothy R.B. Johnson, John J. Voorhees, Frank Wang · 2021 · International Journal of Women’s Dermatology
Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis
Jue Tang, Siqi Zhao, Huijuan Shi, Xuan Li, Liwei Ran, Jiali Cao, Yanling He · 2024 · Experimental Dermatology
Recent advancements in nanoparticle-based topical drug delivery systems for psoriasis treatment
Ritwik Mitra, Dinesh Kumar Sharma, Arnab Ghosh, Sahil Senapati · 2025 · Journal of drug targeting
Screening for depression in psoriasis patients during a dermatological consultation: A first step towards treatment
Christian Kromer, Johannes Mohr, Daniel Celis, Sietske Poortinga, Sascha Gerdes, Rotraut Mößner, Dagmar Wilsmann‐Theis · 2021 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study
Nicole Salame, Nazanin Ehsani‐Chimeh, April Wang Armstrong · 2018 · Journal of Dermatological Treatment
Guselkumab in the treatment of moderate-to-severe plaque psoriasis
Cristina López‐Sánchez, L. Puig · 2020 · Immunotherapy
Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians
Charlotte Read, April Wang Armstrong · 2020 · JAMA Dermatology
Brodalumab in the treatment of chronic plaque psoriasis
Paolo Gisondi, Giampiero Girolomoni · 2020 · Expert Opinion on Biological Therapy
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity
Maria Esposito, Alessandro Giunta, Roberta Croce Nanni, Silvia Criscuolo, Valeria Manfreda, Ester DEL DUCA, Luca Bianchi, Alfonso Troisi · 2020 · Archives of Dermatological Research
Internalized Stigma and Psychiatric Morbidity among Patients with Psoriasis
Sandeep Grover, Aseem Mehra, Sunil Dogra, Nandita Hazari, Nidhi Malhora, Tarun K. Narang, Swapanjeet Sahoo, Sunil Kumar Sharma, Sanjeev Handa, Ajit Avasthi · 2021 · Indian Dermatology Online Journal
Underscreening of depression in U.S. outpatients with atopic dermatitis and psoriasis
P. Singh, Jonathan I. Silverberg · 2019 · British Journal of Dermatology
Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients
Maria-Lorena Mustață, Carmen Daniela Neagoe, Virginia Maria Rădulescu, Ioana-Gabriela Dragne, Radu-Cristian Cîmpeanu, Lucreţiu Radu, Roxana-Viorela Ahrițculesei, Dragoș Forțofoiu, Maria-Cristina Predoi, Simona-Laura Ianoși · 2025 · Life
Quality of Life and Its Associated Factors among Patients with Psoriasis in a Semi-Urban Northeast Malaysia
Mohd Shahriman Ahmad Fuat, Zainab Mat Yudin, Juliawati Muhammad, Faridah Mohd Zin · 2022 · International Journal of Environmental Research and Public Health
Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review
Meng Wang, Yanhong Sun, Yonghu Sun · 2024 · Journal of Affective Disorders
Psoriasis and progression of Parkinson's disease: a Mendelian randomization study
C. Li, Xiao Li, Junyu Lin, Y. Cui, Huifang Shang · 2022 · Journal of the European Academy of Dermatology and Venereology
Suicidality and risk of suicidality in psoriasis: a critical appraisal of two systematic reviews and meta‐analyses
Uwe Matterne, Sebastian‐Edgar Baumeister, Christian Apfelbacher · 2019 · British Journal of Dermatology
Prevalence and predictors of depression among dermatology clinic patients in a teaching hospital, Jeddah, Saudi Arabia
Nouf Talal Mleeh, Hussein M. Alshamrani, Reem N Basyouni, Khalid Alshehri, Mohammed R. Algethami, Mohammad Gamal Sehlo · 2019 · Journal of Family Medicine and Primary Care
Two questions may be enough – screening for depression in patients with psoriasis: a multicenter study
Sascha Gerdes, Dagmar Wilsmann‐Theis, Daniel Celis, Christian Kromer, Rotraut Mößner · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
Eric Yang, Mary Patricia Smith, Karen Ly, Tina Bhutani · 2019 · Drug Design Development and Therapy
Psychological morbidity in patients with pemphigus and its clinicodemographic risk factor: A comparative study
Jingying Wang, Haixi Wu, Weiting Cong, Haiqin Zhu, Jie Zheng, Xia Li, Meng Pan · 2023 · The Journal of Dermatology
Dose‐response analysis between alcohol consumption and psoriasis: A systematic review and meta‐analysis
Jeeyu Choi, Ikjoon Han, Joohong Min, Jisang Yun, Byung‐Soo Kim, Kihyuk Shin, Kihun Kim, Yun Hak Kim · 2024 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
The association between the clinical diversity of psoriasis and depressive symptoms: the HUNT Study, Norway
Ellen Heilmann Modalsli, Bjørn Olav Åsvold, Ingrid Snekvik, P. R. Romundstad, Luigi Naldi, Marit Saunes · 2017 · Journal of the European Academy of Dermatology and Venereology
Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials
Seth T. Howell, Leah A. Cardwell, Steven R. Feldman · 2017 · Annals of Pharmacotherapy
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross‐sectional study in Italy
Emanuele Scala, Robert Kaczmarczyk, Alexander Zink, Anna Balato, PSES study group · 2022 · Dermatologic Therapy
RETRACTED: Exploring the role of biologics in depression
Tarapati Rani, Tapan Behl, Neelam Sharma, Hafiz Antar Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya, Saurabh Bhatia, SIMONA GABRIELA BUNGAU · 2022 · Cellular Signalling · Retracted
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study
Chika Ohata, Yasumasa Kanai, Kenta Murotani, Fumikazu Yamazaki, Hidetoshi Takahashi, Yayoi Tada, Tomotaka Mabuchi, Yoko Mizutani, Takanobu Nomura, Shinichi Imafuku · 2023 · Dermatology and Therapy
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis
Donald E. Stull, Christopher E.M. Griffiths, Isabelle Gilloteau, Yang Zhao, Adriana Guana, Andrew Yule Finlay, Bintu N. Sherif, Katherine Houghton, L. Puig · 2018 · British Journal of Dermatology
Documento de consenso sobre las necesidades psicológicas de los pacientes con enfermedades inflamatorias crónicas dermatológicas
Miquel Ribera, Sandra Ros, B. Madrid, Ricardo Ruíz‐Villaverde, Francisco José Rebollo, Susana Gómez, Estíbaliz Loza, Gregorio Carretero · 2018 · Actas Dermo-Sifiliográficas
Study on the psychological health and related risk factors in 245 patients with psoriasis in Inner Mongolia
Qiang Zhang, Jianwen Han, Yan Zhang, Changxing Li, Pingjiao Chen, Jing Zhang, Kang Zeng · 2019 · Psychology Health & Medicine
Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study
Salvatore Cipolla, Pierluigi Catapano, Antonio Fiorino Bonamico, Valeria De Santis, Roberta Murolo, Francesca Romano, Antonio Volpicelli, Francesco Perris, Ada Lo Schiavo, Michele Fabrazzo et al. · 2024 · Brain Sciences
Associations of serum 25-hydroxyvitamin D concentrations with risks of mortality and cardiovascular disease among individuals with psoriasis
Kaiqing Lin, Ya Miao, Lu Gan, Bin Zhao, Fang Fang, Ru Wang, Xiang Chen, Jiaqi Huang · 2025 · Journal of the American Academy of Dermatology
A Systematic Review of Depression and Anxiety in Adults with Pyoderma Gangrenosum
Meghan L. McPhie, Joshua Fletcher, Myrela O. Machado, Andre Ferrer Carvalho, Vincent Piguet, Afsáneh Alavi · 2021 · Advances in Skin & Wound Care
Curcumin: A Review of its’ Efficacy in the Management of Psoriasis
K.M. Reena, Lalit Singh, Shipra Sharma · 2022 · Drug Delivery Letters
Prevalence and predictors of depressive symptoms among attendees of a tertiary care dermatology clinic in Muscat, Oman
Mohammed Al‐Alawi, Hamed Al Sinawi, Al Mutasim Al Qasabi, Al Moatasem Al Mamari, Sathiya Murthi Panchatcharam, Samir Al‐Adawi · 2018 · International Journal of Dermatology
Guselkumab for the treatment of moderate-to-severe plaque psoriasis
Eric Yang, Isabelle M. Sanchez, Kristen M. Beck, Sahil Sekhon, Jashin J. Wu, Tina Bhutani · 2018 · Expert Review of Clinical Pharmacology
The role of psychological stress in the pathogenesis of psoriasis
Dongyun Lei, Canyi Gong, Bin Wang, Litao Zhang, Guoqiang Zhang, Mao‐Qiang Man · 2025 · Frontiers in Medicine